1.
|
Phase: Phase III, Phase II Type: Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: UKM-MRC-FOCUS3-CR12, FOCUS 3 - CR12, EUDRACT-2008-008323-15, ISRCTN83171665, EU-20960, NCT00975897
|
|
2.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: ECOG-E5397, E5397, NCT00003809
|
|
3.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067468, UAB-9901, IMCL-CP02-9815, NCI-G99-1657, NCT00004227
|
|
4.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000350016, U10CA031946, CALGB-80203, NCT00077233
|
|
5.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA225-006, NCT00063141
|
|
6.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA225-014, NCT00061815
|
|
7.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 to 69 Sponsor: NCI Protocol IDs: NCI-2009-00639, N0147, U10CA025224, CDR0000355132, NCCTG-N0147, ECOG-N0147, NCT00079274
|
|
8.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13423, I4E-MC-JXBC, CP02-0452, NCT00095199
|
|
9.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA225-099, NCT00112294
|
|
10.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: UKM-MRC-COIN-CR10, EU-20516, NCT00182715, EUDRACT-2004-002951-16, ISRCTN27286448, COIN
|
|
11.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EMR 62202-002, NCT00122460
|
|
12.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 to 74 Sponsor: Other Protocol IDs: Nordic VII, EudraCT no.: 2005-000117-34, NCT00145314
|
|
13.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EMR 62202-046, NCT00148798
|
|
14.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CAIRO2, NCT00208546
|
|
15.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EMR 62202-013, NCT00154102
|
|
16.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 to 74 Sponsor: Other Protocol IDs: CDR0000453839, FFCD-PETACC-8, EU-20547, EUDRACT-2005-003463-23, PETACC-8, MERCK-FFCD-PETACC-8, NCT00265811
|
|
17.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: CALGB-C80405, C80405, SWOG-C80405, NCT00265850
|
|
18.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 05-041, NCT00252564
|
|
19.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0522, RTOG 0522, NCT00265941
|
|
20.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N05C4, N05C4, NCCTG N05C4, NCT00362986
|
|
21.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-S0600, S0600, CALGB-SWOG-S0600, ECOG-SWOG-S0600, CAN-NCIC-SWOG-S0600, NCCTG-SWOG-S0600, NCT00499369
|
|
22.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0617, RTOG 0617, NCCTG-N0628, CALGB-30609, NCT00533949
|
|
23.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CO20, CAN-NCIC-CO20, CAN-NCIC-CA182009, CDR0000590316, NCT00640471
|
|
24.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EMR 200048-052, NCT00678535
|
|
25.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EMR 62240-506, NCT00820755
|